|
SLC25A16 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.280200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.287600E-01 |
| Normal-vs-Stage2 |
1.867430E-01 |
| Normal-vs-Stage3 |
6.283400E-01 |
| Normal-vs-Stage4 |
5.498400E-01 |
| Stage1-vs-Stage2 |
3.075000E-01 |
| Stage1-vs-Stage3 |
9.690000E-01 |
| Stage1-vs-Stage4 |
8.455000E-01 |
| Stage2-vs-Stage3 |
3.260200E-01 |
| Stage2-vs-Stage4 |
5.239600E-01 |
| Stage3-vs-Stage4 |
8.355400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.496600E-01 |
| Normal-vs-AfricanAmerican |
1.299040E-01 |
| Normal-vs-Asian |
4.300000E-01 |
| Caucasian-vs-AfricanAmerican |
4.577700E-02 |
| Caucasian-vs-Asian |
9.094400E-01 |
| AfricanAmerican-vs-Asian |
5.284000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.682800E-01 |
| Normal-vs-Female |
6.714200E-01 |
| Male-vs-Female |
1.450230E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.753200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.120000E-02 |
| Normal-vs-Age(61-80Yrs) |
6.939800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.698370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.082500E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.756000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.409400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.033610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.886100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.206400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.935400E-01 |
| Classical-VS-Follicular |
1.493890E-02 |
| Classical-VS-Other |
2.842000E-01 |
| Classical-VS-Normal |
9.615800E-01 |
| Tall-VS-Follicular |
8.095600E-02 |
| Tall-VS-Other |
1.432790E-01 |
| Tall-VS-Normal |
9.466400E-01 |
| Follicular-VS-Other |
6.923800E-01 |
| Follicular-VS-Normal |
6.354200E-02 |
| Other-VS-Normal |
1.965150E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.099700E-02 |
| Normal-vs-N1 |
6.476000E-01 |
| N0-vs-N1 |
3.274200E-01 |
|
|
